Evidence map›Paper›PMID 1309887›Full record

ArticleJournal of virology1992

NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A.

J M Spergel, W Hsu, S Akira, B Thimmappaya, T Kishimoto, S Chen-Kiang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Strategies for cancer gene therapy using adenoviral vectors.Journal of molecular medicine (Berlin, Germany) · 1996
    Review
  18. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

J M SpergelBrookdale Center for Molecular Biology, Mount Sinai School of Medicine, New York, New York 10029.
W Hsu
S Akira
B Thimmappaya
T Kishimoto
S Chen-Kiang
Icahn School of Medicine at Mount Sinai · US

Funding

RNA PROCESSING IN VITRO OF ADENOVIRUS NUCLEOPROTEINSR01AI024404 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI CHEN-KIANG, SELINA Y · 1986 to 1990
–
NIAID NIH HHS AI-24404
6 · The paper itself

Abstract

A cDNA encoding NF-IL6, an interleukin-6 (IL-6)-regulated human nuclear factor of the C/EBP family, is demonstrated to complement the transactivation function of E1A. The endogenous NF-IL6 level varies according to cell type and correlates positively with an IL-6-regulated cellular E1A-substituting activity that was described recently (J.M. Spergel and S. Chen-Kiang, Proc. Natl. Acad. Sci. USA 88:6472-6476, 1991). When expressed by transfection in cells which contain low levels of NF-IL6 and are incapable of complementing the function of E1A proteins, NF-IL6 also transactivates the E1A-responsive E2ae and E1B promoters, to the same magnitude as E1A. Activation by NF-IL6 is concentration dependent and sequence specific: mutational studies of the E2ae promoter suggest that the promoter-proximal NF-IL6 recognition site functions as a dominant negative regulatory site whereas the promoter-distal NF-IL6 recognition site is positively regulated at low NF-IL6 concentrations and negatively regulated when the NF-IL6 level is high. Consistent with these functions, NF-IL6 alone is sufficient to complement an E1A deletion mutant dl312 in viral infection, when expressed at appropriate concentrations. These results identify NF-IL6 as a sequence-specific cellular nuclear factor which regulates E1A-responsive genes in the absence of E1A.

Indexed as

Promoter Regions, GeneticAdenovirus Early ProteinsAdenoviruses, HumanBase SequenceCarcinoma, HepatocellularCCAAT-Enhancer-Binding ProteinsCell LineChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsGene Expression Regulation, ViralHumansInterleukin-6Liver NeoplasmsMolecular Sequence DataNuclear ProteinsOligodeoxyribonucleotidesAdenovirus Early ProteinsCCAAT-Enhancer-Binding ProteinsChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsInterleukin-6Nuclear ProteinsOligodeoxyribonucleotidesOncogene Proteins, ViralTrans-ActivatorsTranscription Factors

Identifiers

PMID1309887
PMCPMC240805
OpenAlexW1818748679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.